Stockscreener 앱 받기
13.39
0.22%
0.03
시간 외 거래:
13.37
-0.02
-0.15%
전일 마감가:
$13.36
열려 있는:
$13.4
하루 거래량:
2.76M
Relative Volume:
0.33
시가총액:
$3.52B
수익:
$6.16B
순이익/손실:
$246.00M
주가수익비율:
14.26
EPS:
0.9387
순현금흐름:
$708.00M
1주 성능:
+0.22%
1개월 성능:
+0.30%
6개월 성능:
+83.68%
1년 성능:
+40.06%
1일 변동 폭
$13.37
$13.40
1주일 범위
$13.36
$13.40
52주 변동 폭
$5.69
$13.48
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.39 | 3.51B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,149.15 | 1.01T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
232.16 | 560.33B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
223.07 | 401.47B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
119.52 | 298.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
181.55 | 288.38B | 60.48B | 10.40B | 8.05B | 3.3297 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-10-27 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-21 | 개시 | Barclays | Overweight |
| 2023-03-16 | 개시 | Raymond James | Outperform |
| 2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 개시 | Piper Sandler | Neutral |
| 2021-09-01 | 개시 | BofA Securities | Buy |
| 2021-07-22 | 개시 | Citigroup | Buy |
| 2021-06-15 | 개시 | JP Morgan | Neutral |
| 2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
What Sparked Organon's Recent Stock Surge - Kavout
(OGN) Risk Channels and Responsive Allocation - Stock Traders Daily
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma to acquire Organon in US$11bn deal - FemTech World
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
OGN Technical Analysis | Trend, Signals & Chart Patterns | ORGANON & CO (NYSE:OGN) - ChartMill
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN) - marketscreener.com
OGN Stock Price, Quote & Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Sun Pharma, Organon filed HSR May 21, waiting period expires June 22 - MLex
OGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share - Stock Titan
Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip - The Ken
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Organon (OGN) Holds Near Support at $13.35 as Stock ConsolidatesInsider Selling Alerts - thelegaladvocate.com
Organon & Co stock (US68622V1061): Shares trade quietly as investors await next catalysts - AD HOC NEWS
Organon & Co is the best performing healthcare stock in April - MSN
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
Organon Stock Holds Steady Near Support as Consolidation ContinuesPCR Spike - thelegaladvocate.com
(OGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Organon Audit Cleared And New Data Put Valuation And Risks In Focus - Yahoo Finance
Sun Pharma to Acquire Organon for $11.75 Billion in All-Cash Transaction - The Healthcare Technology Report.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
Organon & Co. (OGN) Q1 2026 Earnings: EPS Falls Short of Estimates Amid Challenging Environment - thelegaladvocate.com
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal - The Economic Times
Organon to supply Hanmi’s 3 combo drugs in Malaysia, Philippines - koreabiomed.com
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático - GlobeNewswire Inc.
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia - Macau Business
Organon (OGN) price target increased by 25.58% to 11.02 - MSN
10 Incredible Facts About Sun Pharma’s Historic $11.75 Billion Organon Acquisition - AOL.com
Organon & Co. (OGN) Leads Mid-Cap Stocks with Low Forward P/E Ra - GuruFocus
Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy - MSN
Organon & Co stock hits 52-week high at $13.44 By Investing.com - Investing.com Nigeria
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
Organon & Co stock hits 52-week high at $13.44 - Investing.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
1OGN.MI Stock Price, Quote & Chart | ORGANON & CO (BIT:1OGN) - ChartMill
Organon to Present New Research on Access and Value at ISPOR 2026 - BioSpace
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.61%
자본화:
|
볼륨(24시간):